Answers are grounded in this paper and cite their sources.
A sugar amino acid in the peptide backbone marks a novel class of unnatural peptide building blocks with interesting properties. By incorporation of the readily accessible sugar amino acid into peptides, the structure and pharmacokinetics can be influenced directly. This is demonstrated for cyclic and linear somatostatin (1) and enkephalin analogues.
No takes yet. Share an insight, caveat, or question.
Roedern et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: